A Phase Ib, Single-Center, Randomized, Two-Sequence, Placebo-controlled, Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2012
At a glance
- Drugs BMS 986094; Boceprevir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 01 Jun 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.